Tolazamide
Cat. No.:YN481902
| 产品名称: | Tolazamide | 
| CAS No.: | 1156-19-0 | 
| Chemical Name: | N-[[(hexahydro-1H-azepin-1-yl)amino]carbonyl]-4-methyl-benzenesulfonamide | 
| Synonyms: | 甲磺氮草脲; U-17835 | 
| 分子量: | 311.40 | 
| 分子式: | C₁₄H₂₁N₃O₃S | 
| SMILES: | O=S(C1=CC=C(C)C=C1)(NC(NN2CCCCCC2)=O)=O | 
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. | 
| 运输: | Room temperature in continental US; may vary elsewhere. | 
| 产品描述: | Tolazamide 是口服降血糖剂,用于研究 2 型糖尿病。 | 
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: | 
Gopalakrishnan, M., Molinari, E.J., Char-Change, S., et al.Pharmacology of human sulphonylurea receptor SUR1 and inward rectifier K+ channel Kir6.2 combination expressed in HEK-293 cellsBr. J. Pharmacol.129(7),1323-1332(2000)
Wang, P.H., Moeller, D., Flier, J.S., et al.Coordinate regulation of glucose transporter function, number, and gene expression by insulin and sulfonylureas in L6 rat skeletal muscle cellsJ. Clin. Invest.84(1),62-67(1989)
Biederman, J.I., Vera, E., Rankhaniya, R., et al.Effects of sulfonylureas, α-endosulfine counterparts, on glomerulosclerosis in type 1 and type 2 models of diabetesKidney Int.67(2),554-565(2005)